Lunit Cancer Screening

📍 Boston, Massachusetts, United States👥 272 employees💰 Last funded Nov 2021
Software Development🌐 lunit.io
Website LinkedIn
Conquer Cancer through AI. Lunit is a public company that develops medical AI software for cancer screening and treatment. Lunit AI can empower you to enhance diagnostic performance. Our AI for chest x-ray and 2D & 3D mammography has been validated through 100+ publications in peer-reviewed journals such as JAMA Oncology, Lancet Digital Health and Radiology, and is now in use in 3,500+ sites globally. < Lunit AI Suite for Radiology > • Lunit INSIGHT CXR, AI Solution for Chest X-ray • Lunit INSIGHT MMG, AI Solution for Mammography • Lunit INSIGHT DBT, AI Solution for Digital Breast Tomosynthesis • Lunit CXR Triage, AI solution for Chest X-ray Triage *emergency department use, available in the US only *If you are interested in Lunit Oncology, please visit Lunit Oncology’s LinkedIn page.
5
Total investors
1
Early stage
1
Mid stage
2
Late stage
—
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
South Korea
2
China
1
Hong Kong SAR
1
Korea
1
Investor activity2014–2021 · investors recorded per year
20141201512018120212
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Lunit Cancer Screening?
Lunit Cancer Screening has 5 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 2 late-stage investors.
When did Lunit Cancer Screening last raise funding?
The most recent investment in Lunit Cancer Screening recorded on gritt.io was in November 2021.
What industry is Lunit Cancer Screening in?
Lunit Cancer Screening operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Lunit Cancer Screening based?
Lunit Cancer Screening is headquartered in Boston, Massachusetts, United States.